Vigilant Biosciences

Medical Devices & EquipmentSeries BFort Lauderdale, USvigilantbiosciences.com

Latest round

Series B

Last raised

Jul 2016

Total raised

$11M

Investors

2

About Vigilant Biosciences

Founded in 2011 and based in Florida, US, Vigilant Biosciences, Inc. operates as a developer of medical therapies intended to aid in the early detection and prevention of oral and throat cancer by measuring total protein levels and assessing the level of tumor-initiating and stem cell-associated biomarker in the body.

Who invested in Vigilant Biosciences

2 investors across 2 rounds

See all investors in Vigilant Biosciences

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Jul 11, 2016

    Amount

    $5M

    Investors

    Locked

  2. Series B

    Feb 24, 2015

    Amount

    $5.5M

    Investors

    Locked

Questions about Vigilant Biosciences

Who invested in Vigilant Biosciences?

Vigilant Biosciences has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Vigilant Biosciences raised?

Vigilant Biosciences has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Vigilant Biosciences last raise money?

Vigilant Biosciences's most recent round on record is a Series B, in Jul 2016.

What does Vigilant Biosciences do?

Founded in 2011 and based in Florida, US, Vigilant Biosciences, Inc.

Where is Vigilant Biosciences headquartered?

Vigilant Biosciences is headquartered in Fort Lauderdale, US.

Which VCs invest in companies like Vigilant Biosciences?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Vigilant Biosciences's stage. Their profiles are linked below.

Raising like Vigilant Biosciences? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.